Aspire Biopharma Hldgs Q1 EPS $(20.57) Up From $(504.88) YoY, Sales $28.353K

Benzinga Newsdesk www.benzinga.com Negative 63.2%

Neg 63.2% Neu 0% Pos 0%

Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(20.57) per share. This is a 95.93 percent increase over losses of $(504.88) per share from the same period last year. The company reported $28.353 thousand in sales this quarter.